Journal of Hospital Medicine
Copyright © 2014 Society of Hospital Medicine
Edited By: Andrew Auerbach, MD, MPH, SFHM
Impact Factor: 1.839
ISI Journal Citation Reports © Ranking: 2012: 46/155 (Medicine General & Internal)
Online ISSN: 1553-5606
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement
For additional tools visit Author Resources - an enhanced suite of online tools for Wiley Online Library journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.
- Permission Request
- Supplement Policy
- Conflict of Interest Policy Form
- Author Contribution Required Form
- Sample Author Response Letter
The Journal of Hospital Medicine is the premier peer-reviewed publication for the specialty of hospital medicine. The Journal is dedicated to transforming healthcare and revolutionizing patient care.
The Journal of Hospital Medicine advances excellence in hospital medicine through the dissemination of essential research, evidence-based clinical care updates and reviews, and advocacy of safe, effective care for hospitalized patients.
The Journal of Hospital Medicine (JHM) is a peer-reviewed publication of the Society of Hospital Medicine and is published nine (9) times per year. The mission of the Journal is to promote excellence in hospital medicine as a defined specialty through the dissemination of research, evidence-based clinical care, and advocacy of safe, effective care for hospitalized patients. We are most interested in papers that address important advances in hospital medicine and will influence practice. Manuscripts should address common hospitalized patient groups when appropriate, especially geriatrics given the high proportion of such patients.
Manuscripts are accepted for review with the understanding that the same work has not been previously published, that it is not under consideration for publication elsewhere, and that its submission for publication has been approved by all persons listed as authors and by the appropriate authority at the institution where the work was carried out.
If a revision is requested, authors will be afforded 90 days in which to submit. Extensions will be considered on a case-by-case basis.
Word count limits for each article type are included below. Note that references are not included in the count. The maximum number of references allowable is specific to each article type (see below). *Note: all submissions must include the word count on the title page.
Note: Word count limits include the abstract through conclusion (does not include references).
- Original Research (word limit 2,750, references 40): Research of interest should focus on the care of hospitalized patients or hospitalists’ practice, and can fall into three general areas:
- Clinical Research, through a broad spectrum of research is welcome; JHM has specific interests in studies examining health outcomes improvement, value improvement, comparative effectiveness, and health services research.
- Quality Improvement/Implementation Research, again with focus on studies examining the role of hospitalists and hospital medicine in improving the quality and equity of healthcare both in the hospital and afterwards.
- Physician training and educational research, focusing on methods to improve physician performance and patient outcomes through educational programs.
- Original research paper should included a structured abstract (eg, Background, Objective, Design, Methods, Setting/Patients, Results, Conclusions) and can report results of randomized controlled trials, evaluation of diagnostic tests, prospective cohort studies, case controlled studies, or high quality observational or qualitative studies. Please refer to the Author Guidelines for JHM recommendations for reporting results from specific types of research (e.g., the SQUIRE guidelines for reporting of quality improvement programs).
- Brief Reports (word Limit 1500, 15 references, 200-word unstructured abstract): Brief reports provide focused reporting of Original Research findings. Though shortened in format, they should attempt to adhere to guidelines for reporting specific types of research (e.g. SQUIRE or CONSORT).
- Reviews (word limit 2750, references 50): We prefer that reviews target the Society of Hospital Medicine core curriculum topics and strongly prefer systematic reviews compared with narrative reviews. Systematic reviews should summarize a body of evidence aiming to answer a specific clinical question about diagnostic, prognostic, or therapeutic clinical practices. Narrative reviews outside this area should focus on cutting-edge and evolving developments and how these affect hospitalists’ practice.
- Clinical Care Conundrums (word limit 2750, references 20): The Clinical Care Conundrums (CCC) series is based on narrative, clinical problem-solving exercises. Each includes a challenging diagnostic or therapeutic dilemma, which is then synthesized by an expert clinician who is not otherwise familiar with the case in a presentation typical of “morning report.” The expert shares clinical insight at each step and provides a concluding diagnosis based on a review of the literature.
- Note: The CCC series does not accept case reports or case series. Rather, CCC’s follow a specific format that focuses on cases to teach decision making and use of evidence to formulate a clinical approach. Appropriate CCC’s are enigmatic in their presentation, provide multiple opportunities for clinical education, and have a diagnosis relevant to the Journal’s readership.
- Submission process: Authors interested in submitting a CCC should review the examples of CCC’s here, and determine whether their clinical case and review meet the CCC format.
- Prior to preparing the manuscript, prospective authors should submit a concise (<500 words) prospectus using this template and submit it to the managing editor (see contact at the bottom of this page). CCC’s submitted without a prospectus may be returned to the author. The prospectus should describe the clinical situation to be presented, evaluation of the case, and proposed teaching points [see example here].
- If the initial prospectus is thought to be potentially of interest, the authors will then be invited to submit a draft CCC for formal review. Draft CCC’s will then be referred to JHM Editors or National Correspondent(s), JHM reviewers who collaborate in the CCC development process, to be refined into potentially publishable form. Initiation of this collaborative review and revision process does not guarantee acceptance, but is intended to ensure expeditious review of the highest quality CCCs.
- Letter to Editor (word limit 200): We will publish the following categories of Letters: Comments and Responses (comments on papers published in JHM), and Corrections.
- Editorials: Editorials are typically invited by the editor and reflective of research published in a specific issue, with commentary and thematic discussion
- Research Letter (word limit 800): This type can be used in lieu of a Brief Report when the study is limited in scope, its main findings are straight-forward, and the work can be accurately captured within this abbreviated format. Research letters, like other article types, do undergo peer review. Letters should contain only 1 table or 1 figure and 12 references or fewer.
- Article types which we may seek out or rebrand (e.g. reviews or editorials may become penetrating point).
- The Penetrating Point: (contact editor for word/reference limit): Covers the next breakthrough and/or the future of hospital medicine and other related issues by thought leaders inside and outside of health care. Please contact the Editor in advance of submitting an article for this section.
- Transforming Hospital Care: (word limit 2,750, reference 20): Description of interventions that change care delivery in the hospital. For example, descriptions of implementation of quality improvement projects and the outcomes, including barriers that were overcomes, including barriers that were overcome or that blocked implementation. Estabishment of successful teamwork interactions for discharge planning and utilization that changed care delivery would also be an ideal topic. Finally, newly available pharmaceuticals or devices that change care delivery for Hospitalists fit in this catagory.
- We will not consider for publication any article in which a manufacturer played a part in the preparation of the manuscript, interpretation of the results, or analysis of the data either directly or through a surrogate. We believe that the bias introduced by direct pharmaceutical company role in the development and preparation of articles, even if just perceived, cannot be overcome by simple declaration of the relationship. We will consider articles written by experts who declare relationships with companies (e.g., accepting research grants, honoraria, or serving as consultants) and only if any potential conflict of interest have been adequately addressed.
Manuscript Submission Requirements
The Journal of Hospital Medicine is pleased to offer web-based submissions and peer-review. To submit your manuscript online, go to http://mc.manuscriptcentral.com/jhm .
- Prepare your manuscript and illustrations in the appropriate format, according to the instructions given below. Please also be sure that your paper conforms to the scientific and style instructions of the journal.
- If you are submitting for the first time, you will need to create a new account. You can create one for yourself in the system at the submission site by clicking on the “Create Account” button.
- If you are unsure of your password, enter your e-mail address in the “Password Help” box. If you have an account, a temporary password will be e-mailed to you to gain access to your account. Subsequently, to monitor the progress of your manuscript throughout the review process, log in to ScholarOne Manuscripts periodically and check your Author Center.
- When you are ready to submit your manuscript, let the system guide you through the submission process. Online help is available to you at all times during the process by clicking "Get Help Now" in the upper right hand corner of the screen. You are also able to exit and re-enter the submission process at any stage by clicking on “Unsubmitted Manuscripts” in your Author Center and revising your information. When all steps in the submission process are complete, click the “Submit” button located at the bottom right hand corner of the submission screen’s last page. At the end of a successful submission, a confirmation screen with a manuscript number will appear and you will receive an e-mail confirming that the manuscript has been received by the journal. If this does not happen, please check your submission and/or contact tech support at email@example.com .
- All submissions are kept strictly confidential.
Please read the below information listing the components of articles that may be submitted to the Journal of Hospital Medicine. Any manuscripts missing any of the required documents may be unsubmitted.
Cover Letter: A cover letter must be uploaded to ScholarOne Manuscripts upon submission.
Keywords: It is the author's responsibility to provide keywords to appear after the abstract and to be used for the subject index at the end of the volume.
Please follow all formatting instructions detailed below. Manuscripts failing to adhere to the guidelines may be unsubmitted by the Editorial Office.
Please upload all manuscripts as Word documents and label as “Main Document” in ScholarOne Manuscripts. Tables and Digital Images should be uploaded separately as described below. Please be sure to cite all tables and images within the text but do not include tables or images within the main document.
Title Page: All documents must include a title page listing article title; running title (a short version of the title, up to 40 characters); all authors with academic degrees and affiliations; complete mailing address, telephone and fax numbers and email address for corresponding author. All relevant financial conflicts of interest should appear on the title page, as transposed from the ICMJE COI form each author should complete.
Abstracts: Abstracts should accompany all submissions except Editorials, “Handoffs,” "Clinical Care Conundrums," and “View from the Hospital Bed.” The word limit of the abstracts for all submissions is 250 words. Authors of original research and systematic reviews including meta-analyses should submit a structured abstract organized into the following categories, as applicable:
- Original Research: Background, Objective, Design, Setting, Patients, Intervention, Measurements, Results, Conclusions.
- Systematic Reviews, including Meta-analyses: Background, Purpose, Data Sources, Study Selection, Data Extraction, Data Synthesis, Conclusions.
- Articles not in these categories should organize their abstracts as follows: Background, Methods, Results and Conclusion(s)
Manuscript Body: Every effort should be made to avoid jargon, to spell out all nonstandard abbreviations the first time they are mentioned, and to present the contents of the study as clearly and concisely as possible. Manuscripts should normally be divided into four sections as follows:Introduction: The purpose of the study should be described with some background. Citations should be confined to work that is directly relevant and bulk citations should be avoided. If the work is hypothesis-driven, authors are encouraged to include the hypothesis in this section.
- Methods (or Patients and Methods): Describe the study design (e.g., prospective or retrospective, randomized or observational, inclusion and exclusion criteria, duration of study), setting, and the study population (demographics, length of follow-up). Any interventions should be described in detail and how they were implemented. Please provide flowcharts if possible to clarify patient enrollment and loss to follow-up.
- Results: Provide a detailed report on the data obtained during the study. All data in the text must be consistent throughout the manuscript, including any illustrations, legends, or tables.
- Conclusion/Discussion: The Discussion should summarize but not repeat the Results. Be succinct. Is your hypothesis affirmed or refuted? Analyze your data and discuss strengths and limitations of the study. Consider structuring the discussion of research reports and systematic reviews, including meta-analyses, in the following sequence. First, briefly summarize key findings, with particular emphasis on how the findings add to the body of pertinent knowledge. Second, discuss possible mechanisms and explanations for the findings. Third, compare study results with relevant findings from other published work. Fourth, discuss the limitations of the present study and any methods used to minimize or compensate for those limitations. Fifth, mention any crucial future research directions. Sixth, conclude with a brief section that summarizes in a straightforward and circumspect manner the clinical implications of the work.
- Figure legends should be typed double-spaced and numbered with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, each should be explained clearly in the legend. For photomicrographs, the internal scale markers should be defined and the methods of staining should be given.
- For experiments in which humans were studied, you must have approval from an Institutional Review Board (IRB), preferably at the site of the study, and describe your method of informed consent.
- Patients’ names, initials, or hospital numbers should not be used. For experiments on animals, indicate whether the institution’s or the National Research Council’s guide for the care and use of laboratory animals was followed.
- For drugs and chemicals, the generic name should be used at first mention and, preferably, thereafter. A trade name may appear in parentheses and should be capitalized.
- Statistical methods should be described in detail.
- The statement “no significant difference was found between two groups” cannot be made unless a power study was done and the value of alpha or beta is reported.
- Use of the word significant requires reporting of a p value.
- Ninety-five percent confidence intervals should be used whenever possible.
- Use of the word correlation requires reporting of the correlation coefficient.
Tables : All tables should be uploaded separately as Word documents and designated “Table”. There is a 5 table/figure limit for all Original Research and Review articles. Further instructions:
- Do not use color or shading within tables.
- Tables should be numbered consecutively with Arabic numerals in the order of their appearance in the text. Tables should be double-spaced (horizontal lines are used only to separate headings; vertical rules are not used).
- Data appearing in tables should be summarized, not duplicated, in the text. All data cited in the text should be checked carefully against the corresponding data in the tables to ensure that they correspond.
- Provide a concise title that describes each table. Abbreviations used in the table must be defined in a footnote to the table.
- If the table must exceed one typewritten page, duplicate all headings on the second sheet. Very wide tables are difficult and expensive to typeset and should be avoided by breaking up into smaller tables.
Digital Art: All digital art (this includes Figures, Schemes, Charts, etc) must be saved as TIFF or EPS files and designated “Image” UNLESS it is line art which may be submitted as Word documents and designated “Image”. Submission in application file formats or submission as any format other than TIFF or EPS is not recommended. Submission of JPEG, PDF, Excel, PPT, and BMP files will result in the article being unsubmitted. Images should be flattened prior to submission, i.e. files should not contain layers. Please save all images separately and supply numbered headings and captions for each within the document and in the manuscript details. There is a 5 table/figure limit for all Original Research and Review articles. Further instructions:
- Image resolution: All line art should have a resolution yielding 600-1200 dpi. Grayscale and Color Figures must have a resolution yielding 300 dpi. To ensure that your digital graphics are suitable for print purposes please go to Rapid Inspector at: http://rapidinspector.cadmus.com/zwi/index.jsp . This free, stand-alone software application will help you to inspect and verify illustrations right on your computer.
- Image sizing: Art should be created or scaled to the size intended for print; no enlargement or reduction should be necessary. Digital art files should be cropped to remove non-printing borders. Files should be checked carefully for any type, lines, or other elements outside the illustration that are not intended for print. Such elements should be removed before submission. Image orientation should be the same as intended for print.
- Color illustrations: Color illustrations are helpful in demonstrating findings and illustrating concepts. All color figures will be reproduced in full color in the online edition of the journal as well as in print at no cost to the authors.
- Patient identification: Patient identification must be masked in photographs; otherwise, a signed permission statement is required. A simple black box covering the eyes is not sufficient.
Acknowledgements: Acknowledge only persons who have contributed to the scientific content or provided technical support. Authors are responsible for obtaining and submitting to the editorial office written permission from anyone (with a MD or a PhD) named in the Acknowledgements section. The acknowledgement section should precede the reference list. All disclosures/ conflicts of interest should appear on the title page.
- References should be numbered sequentially in the order they are cited in the text.
- All references listed must be cited within the text.
- List references double-spaced in a separate reference section immediately following the text. All references should be in the style described in the American Medical Association Manual of Style. Note the following examples:
- Journal : Qadeer, MA, Richter, JE, Brotman, DJ, Hospital-acquired gastrointestinal bleeding outside the critical care unit. J Hosp Med. 2006; 1:13-20.
- Book (entire) : Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 9th ed. Oxford, England: Blackwell Scientific Publications; 1993.
- Book (chapter) : Cole BR. Cystinosis and cystinuria. In: Jacobson HR, Striker GE, Klahr S, eds. The Principles and Practice of Nephrology. Philadelphia, Pa: BC Decker Inc; 1991:396-403.
- Web site : Health Care Financing Administration. 1996 statistics at a glance. Available at: http://www.hcfa.gov/stats/stathili.htm. Accessed December 2, 1996.
- List all authors when there are six or fewer; for seven or more, list only the first three and add “et al.”
- Use Index Medicus abbreviations for journal names.
- Include references to unpublished material in the text parenthetically, not in the references (e.g., papers in preparation or submitted for publication, papers presented orally at a meeting, personal communication), and submit a letter of permission from the cited persons to cite such communications. In general, avoid citations to unpublished scientific research.
Copyright Transfer Agreement:
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the non-standard CTA
If the OnlineOpen option is not selected the corresponding author will be presented with the Journal of Hospital Medicine non-standard CTA to sign. The terms and conditions of the non-standard CTA can be previewed below:
Terms and Conditions. Please do not complete this PDF until you are prompted to login into Author Services as described above.
Note to Contributors on Deposit of Accepted Version
Certain funders, including the NIH, members of the Research Councils UK (RCUK) and Wellcome Trust require deposit of the Accepted Version in a repository after an embargo period. Details of funding arrangements are set out at the following website: http://www.wiley.com/go/funderstatement. Please contact the Journal production editor if you have additional funding requirements.
Wiley has arrangements with certain academic institutions to permit the deposit of the Accepted Version in the institutional repository after an embargo period. Details of such arrangements are set out at the following website: http://www.wiley.com/go/funderstatement
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:
Creative Commons Attribution License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html
Statements of Disclosure: If needed, please include statements of disclosure for the following: Statement by the responsible author certifying that all coauthors have seen and agree with the contents of the manuscript; author’s statement of responsibility for clinical trial data (if applicable); statement certifying that the submission (aside from abstracts) is not under review by any other publication; and/or disclosure of any financial interest or notification of redundant or duplicate publication; disclosures of financial support from, or equity positions in, manufacturers of drugs or products mentioned in the manuscript; and trial registry information.
Authors’ Professional and Ethical Responsibilities
Authorship: The Journal of Hospital Medicine adheres to the guidelines set by the International Committee of Medical Journals Editors regarding authorship ( www.icmje.org ). Persons designated as authors must meet all of the following criteria:
- Contributing to the conception and design, or analyzing and interpreting data.
- Drafting the article or revising it critically for important intellectual content.
- Approving the final version to be published. Supporting the study or collecting data does not constitute authorship. Authorship based solely on position (e.g., research supervisor, department head) is not permitted.
The Journal of Hospital Medicine adheres to the authorship guidelines set by the International Committee of Medical Journal Editors (www.icmje.org<http://www.icmje.org/>). If you are invited to submit a revised manuscript for possible publication, you will be asked to submit a form detailing the contributions of each author. The form, which must be uploaded as Supplementary Material Not for Review, will appear online as Supporting Information if the article is published. Failure to upload the form with your revision will block further manuscript processing.
Additionally, the editors of JHM follow the Council of Science Editors recommendations regarding our responsibilities to authors (found at http://www.councilscienceeditors.org/services/draft_approved.cfm ).
Conflict of Interest : The Journal of Hospital Medicine complies with the position of the International Committee of Medical Journal Editors on “Conflict of Interest.” Conflict of interest for authors is defined as “financial and other conflicts of interest that might bias their work” ( www.icmje.org ). Authors are responsible for making certain that their final, accepted manuscript and page proofs provide full disclosure of all potential conflicts of interest (financial or non-financial) and any other pertinent final information. If any of the authors or their institution received commercial support for the submitted work (e.g., payment, grant, or assistance with study design, analysis, or manuscript preparation, it must be included on the manuscript's title page. At the revision stage, the ICMJE Conflict of Interest form will be sent to all authors, who must complete the form and return it to the corresponding author, who will transpose all relevant disclosures to the revision so they appear on the title page. All authors must disclose if they, or any immediate family member, within the last three years have had any affiliations that they consider to be relevant and important with any organization that to any author’s knowledge has a direct interest, particularly a financial interest, in the subject matter or materials discussed. Such affiliations include, but are not limited to: employment by an industrial concern, ownership of stock, membership on a standing committee or board of directors, consultancies, or being publicly associated with a company or its products. Other areas of real or perceived conflict of interest include the receipt of honoraria, consulting fees, grants, or funds from such corporations or individuals representing such corporations. Not all relationships represent true conflict of interest. Conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment.
The simplest remedy for conflict of interest is disclosure. In the journal, disclosure will be achieved by the inclusion of a short footnote with each published article.
Of note, we will not consider for publication any article in which a manufacturer played a part in the preparation of the manuscript, either directly or through payment to the author or a surrogate. We believe that the bias introduced by direct pharmaceutical company role in the development and preparation of review articles, even if just perceptual, cannot be overcome by simple declaration of the relationship. We will consider articles written by experts who declare relationships with companies (e.g., accepting research grants, honoraria, or serving as consultants). To learn more about SHM's relationship with industry partners visit http://www.hospitalmedicine.org/Content/NavigationMenu/AboutSHM/IndustryPolicies/Industry_Policies.htm
Ethical Conduct of Research: Research that involves human participants includes investigations that use only human blood, tissue, or medical records. The authors must confirm review of the study by the appropriate institutional review board (IRB) or affirm that the protocol is consistent with the principles of the Declaration of Helsinki (World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-6.) If the authors did not obtain IRB approval before the start of the study, they should so state and explain the circumstances. If the study was exempt from review, the authors must state that such exemption complied with the policy of their local IRB. They should affirm that study participants gave their informed consent or state that an IRB approved conduct of the research without explicit consent from the participants. If patients are identifiable from illustrations, photographs, pedigrees, case reports, or other study data, the authors must submit the release form for each such individual (or copies of the figures with the appropriate release statement) giving permission for publication with the manuscript.
Systematic Reviews and Meta-analyses and PRISMA/MOOSE: Authors of systematic reviews and meta-analyses of randomized controlled trials should consult the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement for guidance on content that should be included in the report. Authors of systematic reviews and meta-analyses of observational studies in epidemiology should consult the MOOSE (Meta-analysis of observational studies in epidemiology) Statement for reporting requirements.
Clinical Trials and CONSORT: Authors reporting the results of randomized, controlled clinical trials must provide a CONSORT statement. This statement includes a checklist (for reviewers) and flow diagram (for publication) detailing the methods used by the authors (www.consort-statement.org). The checklist includes items, based on evidence, that need to be addressed in the report; the flow diagram provides readers with a clear picture of the progress of all participants in the trial, from the time they are randomized until the end of their involvement. The intent is to make the experimental process clearer, flawed or not, so that users of the data can more appropriately evaluate its validity for their purposes.
Manuscripts addressing the evaluation of diagnostic tests should conform to the recommendations of the STARD initiative, which aim to improve the quality of reporting of diagnostic studies ( www.consort-statement.org/stardstatement.htm ). The items in the checklist and the flowchart can help authors to describe essential elements of the design and conduct of their study, the execution of tests, and their results.
Clinical Trials Registration: Investigators should register clinical trials in a public registry. A clinical trial is any study that prospectively assigns human participants to intervention and comparison groups to investigate the cause-and-effect relationship between a medical intervention and a health outcome. JHM will consider only registered clinical trials for publication. Before this date, registration is highly recommended but not mandatory. Trials that begin enrollment on or after July 1, 2005 must be registered at or before the onset of patient enrollment. JHM will accept retrospective registration (registration after enrollment begins) before July 1, 2005.
Investigators should use registries that meet the following minimum criteria:
- Available to the public at no charge
- Open to all prospective registrants
- Managed by a not-for-profit organization
- Validates mechanism of the registration data
- Electronically searchable
- Contains the following information: unique identifying number, intervention(s) and comparison(s) studied, study hypothesis, primary and secondary outcome measures, eligibility criteria, key trial dates (registration, anticipated or actual start of study anticipated or actual last follow-up, planned or actual closure to data entry, and completion of data), target number of participants, funding source, contact information for the principal investigators. Authors can obtain current information on acceptable registries at http://www.icmje.org . Until the start of mandatory registration, JHM will consider registration in any publicly available registry sufficient. Scientific Misconduct and Breach of Publication Ethics Scientific Misconduct includes fabrication, falsification, and plagiarism with intent to deceive by the authors. Honest errors or differences in interpretation are not considered misconduct. Breaches of publication ethics include: failure to reveal financial conflicts of interest; redundant or duplicate publications; omitting a deserving author or adding a non-contributing author; misrepresenting publication status in the bibliography (erroneously claiming that a paper is “in press”); and self-plagiarism with attribution. If research misconduct is suspected, the Editor reserves the right to notify and forward the submitted manuscript to the chief executive officer or dean of the sponsoring institution, the funding institution, or other appropriate authority for investigation. The Editor will notify the authors of the journal’s intention to report a suspicion of research misconduct.
Documentation Required For Publication of Accepted Manuscript:CONSORT Flow Chart – Applicable only for clinical trials.>> STARD Statement – Applicable only for studies of diagnostic accuracy. Permission to Reprint – For any previously published material. Ø Informed Consent Forms – For identifiable patient descriptions and photographs. Editorial and Publishing Information Peer Review: The chief criteria for acceptance of papers submitted for publication are the significance, originality, clarity, and the quality of the work reported. We appreciate any recommendations for suggested reviewers. Peer reviewer identities are kept confidential, but author identities are made known to reviewers. Authors can check the status of their manuscript by accessing their password-protected manuscript file at http://mc.manuscriptcentral.com/jhm. Or, please contact the Editorial Office by e-mail at firstname.lastname@example.org. Page Proofs: The Publisher will send electronic proofs to the corresponding author for correction. Please check them carefully as it is the author’s responsibility to ensure that there are no errors in the proofs. Changes done in the course of copyediting to conform to Journal style should be allowed to stand if they do not alter meaning. All changes should be clearly marked and the proofs promptly returned to the Publisher as directed. Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be returned with the corrected proofs, if possible. Notice of Wiley’s Compliance with NIH Grants and Contracts Policy: Recently, the National Institutes of Health (NIH) has requested that its grantees submit copies of manuscripts upon their acceptance for publication to PubMed Central (PMC), a repository housed within the National Library of Medicine. On behalf of our authors who are also NIH grantees, Wiley will deposit in PMC at the same time that the article is published in our journal the peer-reviewed version of the author’s manuscript. Wiley will stipulate that the manuscript may be available for “public access” in PMC 12 months after the date of publication. By assuming this responsibility, Wiley will ensure that authors are in compliance with the NIH request, as well as make certain the appropriate version of the manuscript is deposited. When an NIH grant is mentioned in the Acknowledgements or any other section of a manuscript, Wiley will assume that the author wants the manuscript deposited into PMC, unless the author states otherwise. The author can communicate this via e-mail or a note in the manuscript. The version of the manuscript that Wiley sends to PMC will be the accepted version, i.e. the version that the journal’s Editor-in-Chief sends to Wiley for publication. Wiley will notify the author when the manuscript has been sent to PMC. Because Wiley is taking the responsibility for sending the manuscripts to PMC, in order to ensure an orderly process, authors should not deposit Wiley articles to PMC themselves. Authors should not make corrections to their Wiley-deposited manuscripts in PMC. Wiley reserves the right to change or rescind this policy. For further information, please contact your editorial contact at Wiley or see the NIH Policy on Public Access, located at: http://www.nih.gov/about/publicaccess/.
ResearchGate: ResearchGate is a social networking site for scientists and researchers to share papers, ask and answer questions, and find collaborators. Authors of accepted articles can post the original pre-peer reviewed Word file to their ResearchGate profile with the legend below:
This is the pre-peer reviewed version of the following article: FULL CITE, which has been published in final form at [Link to final article].
Editorial Office Contact Information
Journal of Hospital Medicine
John Wiley & Sons, Inc.
111 River Street
Hoboken, NJ 07030